Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
McKesson
(NYSE:MCK)
Intraday
$519.00
0.19
[0.04%]
After-Hours
$519.00
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$519.00
0.19
[0.04%]
At close: Apr 18
$519.00
0
[0.00%]
PreMarket: 6:03PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for McKesson Stock (NYSE:MCK)
McKesson Stock (NYSE: MCK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 15, 2024
Morgan Stanley Maintains Overweight on McKesson, Raises Price Target to $548
Benzinga Newsdesk
-
3 days ago
Wednesday, April 10, 2024
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
Benzinga Insights
-
Apr 10, 2024, 5:30PM
Argus Research Maintains Buy on McKesson, Raises Price Target to $570
Benzinga Newsdesk
-
Apr 10, 2024, 11:23AM
Wednesday, April 03, 2024
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
Benzinga Insights
-
Apr 3, 2024, 1:00PM
Thursday, March 28, 2024
Peering Into McKesson's Recent Short Interest
Benzinga Insights
-
Mar 28, 2024, 10:15AM
Wednesday, March 27, 2024
Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
Shivani Kumaresan
-
Mar 27, 2024, 5:54AM
Tuesday, March 26, 2024
McCormick Reaffirms FY24 Sales Growth Outlook Of (2)% - 0%; Adj EPS Of $2.80 - $2.85 Vs. $2.83 Est.
Benzinga Newsdesk
-
Mar 26, 2024, 6:35AM
Monday, March 18, 2024
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Benzinga Insights
-
Mar 18, 2024, 12:00PM
Which Stocks Will Dominate The Future Of Tech? UBS Shares Its Top Picks In AI, Healthtech, Greentech, And Fintech
Benzinga Neuro
-
Mar 18, 2024, 3:14AM
Wednesday, March 06, 2024
UBS Maintains Buy on McKesson, Raises Price Target to $620
Benzinga Newsdesk
-
Mar 6, 2024, 12:43PM
Tuesday, February 27, 2024
How Is The Market Feeling About McKesson?
Benzinga Insights
-
Feb 27, 2024, 8:45AM
Monday, February 26, 2024
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
Benzinga Insights
-
Feb 26, 2024, 12:30PM
Leerink Partners Initiates Coverage On McKesson with Outperform Rating, Announces Price Target of $600
Benzinga Newsdesk
-
Feb 26, 2024, 8:45AM
Wednesday, February 14, 2024
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
Vandana Singh
-
Feb 14, 2024, 1:25PM
Friday, February 09, 2024
Mizuho Maintains Neutral on McKesson, Raises Price Target to $505-Report released on 8th February 2024
Benzinga Newsdesk
-
Feb 9, 2024, 10:51AM
Thursday, February 08, 2024
Medical Supplies-Focused McKesson Shares Fall On Q3 Earnings Performance, Analyst Says Street 'Wanted More'
Vandana Singh
-
Feb 8, 2024, 2:29PM
Citigroup Maintains Buy on McKesson, Raises Price Target to $575
Benzinga Newsdesk
-
Feb 8, 2024, 11:20AM
McKesson shares are trading lower after the company reported Q3 financial results.
Benzinga Newsdesk
-
Feb 8, 2024, 9:48AM
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today
Benzinga Insights
-
Feb 8, 2024, 9:30AM
Wednesday, February 07, 2024
McKesson shares are trading lower after the company reported Q3 financial results.
Benzinga Newsdesk
-
Feb 7, 2024, 4:33PM
McKesson Sees FY24 Adj. EPS $27.25-$27.65 vs $27.32 Est.
Benzinga Newsdesk
-
Feb 7, 2024, 4:10PM
McKesson Q3 2024 Adj EPS $7.74 Beats $7.05 Estimate, Sales $80.90B Beat $77.86B Estimate
Benzinga Newsdesk
-
Feb 7, 2024, 4:09PM
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
Piero Cingari
-
Feb 7, 2024, 1:40PM
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Avi Kapoor
-
Feb 7, 2024, 10:04AM
Earnings Scheduled For February 7, 2024
Benzinga Insights
-
Feb 7, 2024, 5:13AM
Fear & Greed Index Remains In 'Greed' Zone Following Earnings Reports; Dow Jumps Over 100 Points
Avi Kapoor
-
Feb 7, 2024, 4:54AM
Tuesday, February 06, 2024
Earnings Preview: McKesson
Benzinga Insights
-
Feb 6, 2024, 9:02AM
Monday, January 29, 2024
UBS Maintains Buy on McKesson, Raises Price Target to $559
Benzinga Newsdesk
-
Jan 29, 2024, 11:13AM
Friday, January 19, 2024
Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today
Benzinga Insights
-
Jan 19, 2024, 9:00AM
Monday, January 15, 2024
Peering Into McKesson's Recent Short Interest
Benzinga Insights
-
Jan 15, 2024, 9:00AM
Friday, January 05, 2024
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
Benzinga Insights
-
Jan 5, 2024, 12:00PM
Wednesday, January 03, 2024
Check Out What Whales Are Doing With MCK
Benzinga Insights
-
Jan 3, 2024, 2:15PM
Tuesday, January 02, 2024
Exceeding Expectations: McKesson Achieves Strong Performance and Rewards Investors
Benzinga Insights
-
Jan 2, 2024, 10:05AM
Monday, December 25, 2023
How Is The Market Feeling About McKesson?
Benzinga Insights
-
Dec 25, 2023, 1:30PM
Thursday, December 21, 2023
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
Vandana Singh
-
Dec 21, 2023, 8:54AM
Monday, December 18, 2023
Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years
Benzinga Insights
-
Dec 18, 2023, 11:00AM
Thursday, December 14, 2023
Wells Fargo Initiates Coverage On McKesson with Equal-Weight Rating, Announces Price Target of $502
Benzinga Newsdesk
-
Dec 14, 2023, 7:34AM
Monday, December 11, 2023
What 5 Analyst Ratings Have To Say About McKesson
Benzinga Insights
-
Dec 11, 2023, 10:00AM
TD Cowen Maintains Outperform on McKesson, Raises Price Target to $563
Benzinga Newsdesk
-
Dec 11, 2023, 9:33AM
Friday, December 08, 2023
How Is The Market Feeling About McKesson?
Benzinga Insights
-
Dec 8, 2023, 11:15AM
Monday, December 04, 2023
Teamsters At McKesson In Sacramento, California, Have Voted To Authorize A Strike If The Company Fails To Reach Agreement On A Fair Contract
Benzinga Newsdesk
-
Dec 4, 2023, 3:56PM
Friday, December 01, 2023
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today
Benzinga Insights
-
Dec 1, 2023, 10:30AM
Wednesday, November 22, 2023
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
Benzinga Insights
-
Nov 22, 2023, 2:00PM
(MCK) - Analyzing McKesson's Short Interest
Benzinga Insights
-
Nov 22, 2023, 8:30AM
Friday, November 17, 2023
JP Morgan Maintains Overweight on McKesson, Raises Price Target to $514
Benzinga Newsdesk
-
Nov 17, 2023, 10:30AM
Wednesday, November 15, 2023
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Nov 15, 2023, 12:35PM
Friday, November 10, 2023
Qualcomm, Merck And 2 Other Stocks Insiders Are Selling
Lisa Levin
-
Nov 10, 2023, 8:04AM
Monday, November 06, 2023
Peering Into McKesson's Recent Short Interest
Benzinga Insights
-
Nov 6, 2023, 2:15PM
Friday, November 03, 2023
Analyst Ratings for McKesson
Benzinga Insights
-
Nov 3, 2023, 8:00AM
Thursday, November 02, 2023
Mizuho Maintains Neutral on McKesson, Raises Price Target to $450
Benzinga Newsdesk
-
Nov 2, 2023, 4:24PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch